Rylaze

Jazz plays coda to blood cancer approval, securing FDA nod for revised dosing schedule
Fierce Pharma
Tue, 11/22/22 - 04:41 pm
Jazz Pharmaceuticals
FDA
Rylaze
blood cancer
acute lymphoblastic leukemia
lymphoblastic lymphoma
CEL-SCI, Jazz, CARsgen, Ascentage and Portage Showcase New Data at ASCO
BioSpace
Wed, 06/8/22 - 10:37 am
ASCO 2022
oncology
Cel-Sci
Jazz Pharmaceuticals
CARsgen
Ascentage
Portage
Rylaze
Multikine
olverembatinib
CT041
Jazz Pharma (JAZZ) Gets FDA Approval for Leukemia Drug Rylaze
Yahoo/Zacks.com
Thu, 07/1/21 - 10:33 am
Jazz Pharmaceuticals
FDA
Rylaze
JZP-458
acute lymphoblastic leukemia
lymphoblastic lymphoma